ATE376056T1 - Mn gen und protein - Google Patents
Mn gen und proteinInfo
- Publication number
- ATE376056T1 ATE376056T1 AT99955151T AT99955151T ATE376056T1 AT E376056 T1 ATE376056 T1 AT E376056T1 AT 99955151 T AT99955151 T AT 99955151T AT 99955151 T AT99955151 T AT 99955151T AT E376056 T1 ATE376056 T1 AT E376056T1
- Authority
- AT
- Austria
- Prior art keywords
- protein
- proteins
- polypeptides
- disclosed
- encode
- Prior art date
Links
- 108090000623 proteins and genes Proteins 0.000 title abstract 11
- 102000004169 proteins and genes Human genes 0.000 title abstract 8
- 229920001184 polypeptide Polymers 0.000 abstract 5
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 5
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 5
- 239000013598 vector Substances 0.000 abstract 3
- 241000251539 Vertebrata <Metazoa> Species 0.000 abstract 2
- 102000004127 Cytokines Human genes 0.000 abstract 1
- 108090000695 Cytokines Proteins 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 230000017455 cell-cell adhesion Effects 0.000 abstract 1
- 239000003145 cytotoxic factor Substances 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 230000001613 neoplastic effect Effects 0.000 abstract 1
- 230000001855 preneoplastic effect Effects 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
- 230000035897 transcription Effects 0.000 abstract 1
- 238000013518 transcription Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/82—Translation products from oncogenes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/88—Lyases (4.)
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- General Engineering & Computer Science (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/177,776 US6297051B1 (en) | 1997-01-24 | 1998-10-23 | MN gene and protein |
| US09/178,115 US6297041B1 (en) | 1992-03-11 | 1998-10-23 | MN gene and protein |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE376056T1 true ATE376056T1 (de) | 2007-11-15 |
Family
ID=26873634
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99955151T ATE376056T1 (de) | 1998-10-23 | 1999-10-22 | Mn gen und protein |
Country Status (11)
| Country | Link |
|---|---|
| EP (2) | EP1832653A1 (enExample) |
| JP (3) | JP3910798B2 (enExample) |
| AT (1) | ATE376056T1 (enExample) |
| AU (1) | AU758957C (enExample) |
| CA (1) | CA2347649C (enExample) |
| CY (1) | CY1107268T1 (enExample) |
| DE (1) | DE69937364T2 (enExample) |
| DK (1) | DK1123387T3 (enExample) |
| ES (1) | ES2296412T3 (enExample) |
| NO (1) | NO328884B1 (enExample) |
| WO (1) | WO2000024913A2 (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6902890B1 (en) | 1999-11-04 | 2005-06-07 | Diadexus, Inc. | Method of diagnosing monitoring, staging, imaging and treating cancer |
| US20040077081A1 (en) | 2001-02-07 | 2004-04-22 | Egbert Oosterwijk | Hybridoma cell line g250 and its use for producing monoclonal antibodies |
| AR036833A1 (es) * | 2001-10-18 | 2004-10-06 | Bayer Corp | Anticuerpos humanos que se unen a mn y tienen actividad neutralizante de la adhesion celular. |
| US7910549B2 (en) * | 2001-12-13 | 2011-03-22 | Institute Of Virology Of The Slovak Academy Of Sciences | MN gene and protein |
| AU2003217606C1 (en) | 2002-02-21 | 2008-07-17 | Institute Of Virology | Soluble Form of Carbonic Anhydrase IX (s-CA IX), Assays to Detect s-CA IX, CA IXs Coexpression with HER-2/neu/c-erbB-2 and CA IX-Specific Monoclonal Antibodies to Non-Immunodominant Epitopes |
| DK2508596T3 (en) | 2002-02-21 | 2015-10-19 | Inst Virology | MN / CA IX-specific monoclonal antibodies generated from MN / CA IX-poor mice, as well as methods of use. |
| AU2003223186A1 (en) * | 2002-05-23 | 2004-01-23 | Bayer Healthcare | SOLUBLE FORM OF CARBONIC ANHYDRASE IX (s-CA IX), ASSAYS TO DETECT s-CA IX AND CA IX's COEXPRESSION WITH HER-2/neu/c-erbB-2 |
| ATE537842T1 (de) | 2002-07-01 | 2012-01-15 | Wilex Ag | Zusammesetzungen von cg250 und il-2 oder von cg250 und ifn-alpha zur krebsbehandlung des nierenzell karzinoms |
| EP1576010A4 (en) * | 2002-08-23 | 2006-12-27 | Chiron Corp | THERAPEUTIC COMPOSITIONS AND METHODS FOR CANCER CHARACTERIZED BY EXPRESSION OF MN / CA IX ANTIGEN ASSOCIATED WITH TUMORS |
| EP1569633A4 (en) | 2002-11-26 | 2008-03-05 | Inst Virology | CA-IX SPECIFIC HEMMER |
| US7524634B2 (en) * | 2003-10-16 | 2009-04-28 | Institute Of Virology, Slovak Academy Of Sciences | MN/CA IX and cancer prognosis |
| AU2005241093B2 (en) | 2004-05-04 | 2008-06-05 | Institute Of Virology Of Slovak Academy Of Sciences | MN/CA IX/ CA9 and renal cancer prognosis |
| US7820159B2 (en) | 2006-10-31 | 2010-10-26 | Instiute of Virology of the Slovak Academy of Sciences | MN/CA IX and EGFR pathway inhibition |
| US8399625B1 (en) * | 2009-06-25 | 2013-03-19 | ESBATech, an Alcon Biomedical Research Unit, LLC | Acceptor framework for CDR grafting |
| BR112015020061A8 (pt) | 2013-02-22 | 2018-01-23 | Wilex Ag | composto alvo anidrase carbônica ix (caix) para tratamento de câncer, seus usos, composição farmcêutica, e método para diagnosticar, prognosticar e/ou classificar um câncer |
| CZ2014527A3 (cs) * | 2014-08-05 | 2016-02-17 | Ústav Organické Chemie A Biochemie Akademie Věd Čr, V.V.I. | Způsob detekce aktivní formy analytů ve vzorku a stanovení schopnosti dalších látek vázat se do aktivních míst těchto analytů |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1995034650A2 (en) * | 1994-06-15 | 1995-12-21 | Ciba Corning Diagnostics Corp. | Mn gene and protein |
| US6329501B1 (en) * | 1997-05-29 | 2001-12-11 | Auburn University | Methods and compositions for targeting compounds to muscle |
| WO1999058561A1 (fr) * | 1998-05-14 | 1999-11-18 | Pasteur Merieux Serums & Vaccins | Mimotopes du virus de l'hepatite c |
-
1999
- 1999-10-22 AU AU11323/00A patent/AU758957C/en not_active Expired
- 1999-10-22 AT AT99955151T patent/ATE376056T1/de active
- 1999-10-22 EP EP06076937A patent/EP1832653A1/en not_active Withdrawn
- 1999-10-22 DE DE69937364T patent/DE69937364T2/de not_active Expired - Lifetime
- 1999-10-22 CA CA2347649A patent/CA2347649C/en not_active Expired - Lifetime
- 1999-10-22 WO PCT/US1999/024879 patent/WO2000024913A2/en not_active Ceased
- 1999-10-22 ES ES99955151T patent/ES2296412T3/es not_active Expired - Lifetime
- 1999-10-22 EP EP99955151A patent/EP1123387B1/en not_active Expired - Lifetime
- 1999-10-22 DK DK99955151T patent/DK1123387T3/da active
- 1999-10-22 JP JP2000578465A patent/JP3910798B2/ja not_active Expired - Fee Related
-
2001
- 2001-04-19 NO NO20011926A patent/NO328884B1/no not_active IP Right Cessation
-
2006
- 2006-11-27 JP JP2006318591A patent/JP4044597B2/ja not_active Expired - Lifetime
-
2007
- 2007-09-10 JP JP2007233872A patent/JP4488373B2/ja not_active Expired - Fee Related
-
2008
- 2008-01-16 CY CY20081100058T patent/CY1107268T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP1123387B1 (en) | 2007-10-17 |
| AU1132300A (en) | 2000-05-15 |
| EP1832653A1 (en) | 2007-09-12 |
| ES2296412T3 (es) | 2008-04-16 |
| AU758957B2 (en) | 2003-04-03 |
| CA2347649C (en) | 2012-03-13 |
| WO2000024913A2 (en) | 2000-05-04 |
| JP3910798B2 (ja) | 2007-04-25 |
| NO328884B1 (no) | 2010-06-07 |
| NO20011926L (no) | 2001-06-19 |
| JP4488373B2 (ja) | 2010-06-23 |
| DE69937364T2 (de) | 2008-07-17 |
| JP2007145843A (ja) | 2007-06-14 |
| DE69937364D1 (de) | 2007-11-29 |
| JP2002528085A (ja) | 2002-09-03 |
| AU758957C (en) | 2004-08-12 |
| JP4044597B2 (ja) | 2008-02-06 |
| DK1123387T3 (da) | 2008-02-25 |
| JP2008069151A (ja) | 2008-03-27 |
| WO2000024913A3 (en) | 2000-09-14 |
| CA2347649A1 (en) | 2000-05-04 |
| EP1123387A2 (en) | 2001-08-16 |
| CY1107268T1 (el) | 2012-11-21 |
| NO20011926D0 (no) | 2001-04-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1107268T1 (el) | Μν γονιδιο και πρωτεϊνη | |
| NO20100685L (no) | Polypeptid samt anvendelse derav og peptidkompleks, og fremgangsmate for identifisering av et organisk eller uorganisk molekyl | |
| DK368588A (da) | Bindingsmolekyler med en enkelt polypeptidkaede | |
| NO990086D0 (no) | Avkortete, oppl÷selige tumornekrosefaktorreseptorer av type I og type II | |
| ATE365744T1 (de) | Nukleinsäuremoleküle, proteine und peptide, die im zusammenhang stehen mit dickdarmzellen und dickdarm-krebszellen | |
| ATE541931T1 (de) | Il-17-homologe polypeptide und ihre therapeutische verwendung | |
| DK1294876T3 (da) | EV-VEGF-nukleinsyrer og -polypeptider samt fremgangsmåder til deres benyttelse | |
| NO2007015I1 (no) | Ranibizumab | |
| NO994870D0 (no) | Humaniserte antistoffer og metoder for aa danne humaniserte antistoffer | |
| CA2347131A1 (en) | Modified peptides as therapeutic agents | |
| DE69534588D1 (de) | Protocadherin-proteine und verwendungen davon | |
| ATE385504T1 (de) | Nukleinsäuren und polypeptide, die sich auf b7 beziehen und ihre verwendungen zur immunmodulierung | |
| WO2002092758A8 (en) | Gastrokines and derived peptides including inhibitors | |
| WO2002005843A3 (en) | Human rrp sequences and methods of use | |
| BR0008187A (pt) | Controle biológico de nematódeos | |
| DE60313743D1 (de) | Mit influenzavirus-hämagglutinin und influenza m2 pseudotypisierte retrovirusvektoren zur zuführung von genen | |
| EP0643728A4 (en) | PROTEIN RELATED TO INTERCELLULAR ADHESION MOLECULES. | |
| NO970546L (no) | ICAM-4-materialer og metoder | |
| SE0003573D0 (sv) | Method and means for producing novel von Willebrand factor binding proteins and their use in biotechnology | |
| DE59309978D1 (de) | Verfahren zur Herstellung von rekombinanten und synthetischen Peptiden und deren Verwendung | |
| DK1233980T3 (da) | Nukleinsyremolekyle, omfattende en nukleinsyresekvens, der koder for et hæmocyanin, og mindst en intronsekvens | |
| DK1105485T3 (da) | Human IL-1-epsilon-DNA og polypeptider | |
| DE69941299D1 (de) | Zusammensetzungen und verfahren zur behandlung der polyzystischen nierenkrankheit | |
| HOROWITZ | CYCLIC-AMP-DEPENDENT PROTEIN KINASE REGULATION OF SPERM MOTILITY | |
| DK1191101T3 (da) | PRO241 polypeptider og nucleinsyre kodende herfor |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1123387 Country of ref document: EP |